maaf email atau password anda salah

Other Tempo Media
Majalah Tempo
Koran Tempo
Tempo.co
Subscribe

Beneficial Side Effects of Worm Drug

Sunday, June 27, 2021

The government’s plan to use ivermectin as Covid-19 medication sparks controversy. The health ministry will conduct clinical testing on the medicine which is officially used to treat intestinal worms.

arsip tempo : 173224824740.

Searching online for Ivermectin, a drug used in Covid-19 treatment, 25 June. Tempo/Nurdiansah . tempo : 173224824740.

“WHEN was the last time you had worms?” Zullies Ikawati, pharmacy professor at the Gadjah Mada University in Yogyakarta, asked this question when discussing ivermectin, an anthelmintic medication used to treat parasite infestations which is currently widely being discussed. “This is not a very well-known drug. I’ve only heard about it after it came up in public discussions,” said Zullies on Wednesday, June 23. W

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 54.945/Month

Active for 12 Months, Rp 659.340

  • *You Save -Rp 102.000
  • *Guaranteed update of up to 52 Editions of Tempo Magazine
Subscribe

Rp 64.380/Month

Active Every Month Cancel Anytime

  • *Free for the first month if using a Credit Card
Subscribe

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

Abdul Manan

Covid-19 Ivermectin controversy
Prev Next

More Articles

More exclusive contents

  • November 18, 2024

  • November 11, 2024

  • November 4, 2024

  • October 28, 2024

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe